MIM
VXRT

Macroview Investment Management’s Vaxart VXRT Stock Holding History

Macroview Investment Management’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-361
Closed -$307 – 544
2024
Q3 		$307 Hold
361
– – ﹤0.01% 551
2024
Q2 		$241 Hold
361
– – ﹤0.01% 560
2024
Q1 		$470 Hold
361
– – ﹤0.01% 595
2023
Q4 		$207 Hold
361
– – ﹤0.01% 600
2023
Q3 		$273 Hold
361
– – ﹤0.01% 752
2023
Q2 		$264 Hold
361
– – ﹤0.01% 463
2023
Q1 		$274 Hold
361
– – ﹤0.01% 424
2022
Q4 		$347 Hold
361
– – ﹤0.01% 425
2022
Q3 		$1K Hold
361
– – ﹤0.01% 396
2022
Q2 		$1K Hold
361
– – ﹤0.01% 428
2022
Q1 		$2K Hold
361
– – ﹤0.01% 363
2021
Q4 		$2K Hold
361
– – ﹤0.01% 335
2021
Q3 		$3K Hold
361
– – ﹤0.01% 310
2021
Q2 		$3K Hold
361
– – ﹤0.01% 338
2021
Q1 		$2K Buy
+361
New +$2.78K ﹤0.01% 328

Other funds holding VXRT

SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Macroview Investment Management's VXRT Position: Q4 2024 in Review

Macroview Investment Management sold out of Vaxart (VXRT) in Q4 2024, closing a stake of 361 shares — an estimated $307 sold.

Macroview Investment Management first reported a position in VXRT in Q1 2021 and held it in 15 quarters. The position peaked at $3K in Q3 2021. 93 funds tracked by Wall St. Rank hold VXRT as of Q4 2024.

  • Macroview Investment Management reported no remaining Vaxart position as of Q4 2024 after selling out during the quarter.
  • Macroview Investment Management sold 361 Vaxart shares in Q4 2024, an estimated $307.
  • Macroview Investment Management first reported a position in Vaxart in Q1 2021 and held it in 15 quarters.
  • Macroview Investment Management's Vaxart position peaked at $3K in Q3 2021.
  • 93 funds tracked by Wall St. Rank held Vaxart as of Q4 2024.

Based on Macroview Investment Management's 13F filing for Q4 2024, filed 31 Jan 2025.